ALX Oncology Holdings (ALXO) said Wednesday it has appointed Harish Shantharam to the office of chief financial officer to replace Shelly Pinto.
Pinto resigned as its interim CFO but will remain as its senior vice president, finance and chief accounting officer and the principal accounting officer, according to a regulatory filing.
Shantharam previously served as CFO at CymaBay Therapeutics, ALX Oncology said.
Shares of the company were up about 7% in recent trading.
Price: 1.77, Change: +0.12, Percent Change: +6.97
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.